Literature DB >> 3871826

Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

J Parsonnet, R K Hickman, D D Eardley, G B Pier.   

Abstract

Strains of Staphylococcus aureus isolated from patients with toxic shock syndrome (TSS) make a characteristic protein known as toxic-shock-syndrome toxin-1 (TSST-1), but the role of this protein in the pathogenesis of TSS is not certain. We have purified TSST-1 by using a combination of alcohol precipitation, isoelectric focusing, and gel chromatography. TSST-1 has an isoelectric point of 7.2 and a molecular weight of 23,100, in accordance with previously published determinations for this protein, and is serologically identical to pyrogenic exotoxin C and staphylococcal enterotoxin F. In highly purified form, TSST-1 is a potent inducer of interleukin-1 production by human monocytes, as quantitated in a thymocyte-proliferation assay. This capability is not attributable to contamination by other staphylococcal products or gram-negative endotoxin and can be blocked by hydrocortisone. Many features of TSS suggest that induction of interleukin-1 by TSST-1 in vivo may play a central role in the elaboration of this disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871826     DOI: 10.1093/infdis/151.3.514

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  55 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Coordinate suppression of superantigen-induced cytokine production and T-cell proliferation by a small nonpeptidic inhibitor of class II major histocompatibility complex and CD4 interaction.

Authors:  T Krakauer
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

3.  Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.

Authors:  M A Tomai; P M Schlievert; M Kotb
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

4.  Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.

Authors:  F J Schmitz; C R MacKenzie; R Geisel; S Wagner; H Idel; J Verhoef; U Hadding; H P Heinz
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

5.  Toxic shock syndrome toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk.

Authors:  J Valle; S Vadillo; S Piriz; E Gomez-Lucia
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

6.  B-cell maturation in chronic lymphocytic leukaemia. IV. T-cell-dependent activation of leukaemic B cells by staphylococcal enterotoxin 'superantigens'.

Authors:  X Duan; C Nerl; O Janssen; D Kabelitz
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

7.  Steady-state staphylococcal enterotoxin type C mRNA is affected by a product of the accessory gene regulator (agr) and by glucose.

Authors:  L B Regassa; J L Couch; M J Betley
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

8.  Bacterial croup and toxic shock syndrome.

Authors:  M Chenaud; F Leclerc; A Martinot
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

9.  Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway.

Authors:  F Q Cunha; D W Moss; L M Leal; S Moncada; F Y Liew
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

Review 10.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.